A SpaceX cargo launch slated for Thursday, June 3, will deliver an experiment on kidney stone formation in microgravity.
At-home dialysis is a U.S. priority to stem the growing burden of care that involves people with chronic kidney disease.
Teams in Seattle and Cleveland are pursuing an experiment to regenerate crucial cells and create a new therapy model.
The role in a national trial could validate the technology as a predictor for drug therapies’ effectiveness against patients’ kidney diseases.
A UW Medicine patient was integral to generating global recommendations for care involving diabetes and chronic kidney disease.
The Center for Dialysis Innovation earns acclaim for a porous synthetic graft intended to make the blood-cleansing process safer and more reliable.
Investigators are dejected that the large study did not support treating this patient population with a familiar, inexpensive drug.
Vitamin D and fish oil don’t prevent loss of kidney function in adults with type 2 diabetes, a clinical study shows.
Kidneys-on-a-chip that rocketed to the International Space Station in May returned via a Pacific Ocean splashdown June 3 in the same Dragon capsule. The devices, part of Tissue Chips in Space, are now back in Seattle.
UW center submitted 2 of 16 concepts chosen as finalists; focus is relief for kidney-failure patients.
